You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

M7824

Showing 1 - 25 of 90
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

NSCLC Trial in Heidelberg (89Zirconium-M7824, M7824)

Terminated
  • Non-Small Cell Lung Cancer
  • 89Zirconium-M7824
  • M7824
  • Heidelberg, Victoria, Australia
    Austin Health
Jan 13, 2023

Kaposi Sarcoma Trial run by the NCI (NHS-IL12, M7824)

Recruiting
  • Kaposi Sarcoma
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 25, 2023

Urothelial Cancer, Bladder Cancer, Genitourinary Cancer Trial run by the NCI (M7824, M9241, Stereotactic body radiation therapy

Recruiting
  • Urothelial Cancer
  • +4 more
  • M7824
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 23, 2023

Metastatic Prostate Cancer, Prostate Cancer, Prostate Tumor Trial run by the NCI (M7824, N-803, MVA-BN-Brachyury)

Recruiting
  • Metastatic Prostate Cancer
  • +4 more
  • M7824
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 20, 2023

Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Triple-Negative Breast Carcinoma, Prognostic Stage IV Breast Cancer AJCC v8

Terminated
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +2 more
  • Bintrafusp Alfa
  • Eribulin Mesylate
  • Houston, Texas
  • +1 more
Oct 27, 2022

Head Neck Cancer, Head and Neck Tumors Trial run by the NCI (M7824, N803, TriAd vaccine)

Active, not recruiting
  • Head and Neck Cancer
  • Head and Neck Neoplasms
  • M7824
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 26, 2023

Urothelial Cancer Trial run by the NCI (Bintrafusp alfa (M7824))

Terminated
Has Results
  • Urothelial Cancer
  • Bintrafusp alfa (M7824)
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Feb 25, 2022

Castration Resistant Prostate Cancer Trial run by the National Cancer Institute (NCI) (Bintrafusp alfa, N-803, BN-Brachyury)

Not yet recruiting
  • Castration Resistant Prostate Cancer
  • Bintrafusp alfa
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Feb 2, 2023

Human Papilloma Virus, Cervical Cancer, Oropharyngeal Cancer Trial run by the NCI (M7824)

Active, not recruiting
Has Results
  • Human Papilloma Virus
  • +4 more
  • M7824
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Feb 28, 2022

Histologically or Cytologically Confirmed Pancreatic Cancer, Unresectable or Borderline Resectable Pancreatic Cancer, Pancreatic

Terminated
Has Results
  • Histologically or Cytologically Confirmed Pancreatic Cancer
  • +4 more
  • M7824
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Apr 19, 2022

Metastatic Cancer, Solid Tumors Trial run by the NCI (SX-682, M7824, MVA-BN-CV301)

Active, not recruiting
  • Metastatic Cancer
  • Solid Tumors
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jul 11, 2022

Cancer, Solid Tumor, Metastatic Checkpoint Refractory HPV Associated Malignancies Trial run by the National Cancer Institute

Recruiting
  • Cancer
  • +3 more
  • Bintrafusp Alfa
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 11, 2022

NSCLC Trial in Belgium, France, United States (Cisplatin, Carboplatin, Pemetrexed)

Completed
  • Carcinoma, Non-Small-Cell Lung
  • Fountain Valley, California
  • +18 more
Aug 10, 2022

Prostate Cancer Trial run by the National Cancer Institute (NCI) (PROSTVAC-V, PROSTVAC-F, MSB0011359C (M7824))

Recruiting
  • Prostate Cancer
  • PROSTVAC-V
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 23, 2023

Colon Adenocarcinoma, High-Frequency Microsatellite Instability, Metastatic Malignant Solid Tumor Trial in Houston

Active, not recruiting
  • Colon Adenocarcinoma
  • +10 more
  • Anti-PD-L1/TGFbetaRII Fusion Protein M7824
  • Houston, Texas
    M D Anderson Cancer Center
Jan 12, 2022

Breast Cancer, Triple Negative Breast Cancer, HER2+ Breast Cancer Trial run by the NCI (Brachyury-TRICOM, Entinostat, M7824)

Terminated
Has Results
  • Breast Cancer
  • +4 more
  • Brachyury-TRICOM
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Dec 9, 2021

Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma, Prognostic Stage IV Breast Cancer AJCC v8 Trial in Houston

Completed
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +2 more
  • Bintrafusp Alfa
  • Radiation Therapy
  • Houston, Texas
    M D Anderson Cancer Center
Mar 3, 2022

Cervical Cancer, HPV Cancers, Anal Cancer Trial run by the NCI (PDS0101, M7824, NHS-IL12)

Active, not recruiting
  • Cervical Cancer
  • +4 more
  • PDS0101
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 24, 2023

Solid Tumors Trial in Japan, Korea, Republic of, Taiwan (MSB0011359C)

Completed
  • Solid Tumors
  • Fukuoka, Japan
  • +17 more
Mar 7, 2022

Lung Cancer, Cancer Trial in Rockland, Darmstadt, Madrid (Bintrafusp alfa)

Recruiting
  • Lung Cancer
  • Cancer
  • Bintrafusp alfa
  • Rockland, Massachusetts
  • +2 more
Dec 22, 2021

Cancer Of Prostate, Prostate Tumors Trial run by the National Cancer Institute (NCI) (ADT, Prednisone, M7824)

Recruiting
  • Cancer Of Prostate
  • Prostate Neoplasms
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jul 6, 2022

Mesothelioma; Lung Trial in Spain (Bintrafusp alfa)

Recruiting
  • Mesothelioma; Lung
  • Bintrafusp alfa
  • Badalona, Barcelona, Spain
  • +14 more
Jun 1, 2022

Resectable Lung Non-Small Cell Carcinoma, Stage I Lung Cancer AJCC v8, Stage IA1 Lung Cancer AJCC v8 Trial in Houston

Terminated
Has Results
  • Resectable Lung Non-Small Cell Carcinoma
  • +10 more
  • Bintrafusp Alfa
  • Therapeutic Conventional Surgery
  • Houston, Texas
    M D Anderson Cancer Center
Jul 27, 2022

Olfactory Neuroblastoma, Esthesioneuroblastoma, Tumor of the Nasal Cavity Trial run by the NCI (Bintrafusp alfa / M7824)

Recruiting
  • Olfactory Neuroblastoma
  • +2 more
  • Bintrafusp alfa / M7824
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jul 6, 2022

Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIA Breast Cancer AJCC v8, Anatomic Stage IIB Breast Cancer AJCC v8

Recruiting
  • Anatomic Stage II Breast Cancer AJCC v8
  • +13 more
  • Bintrafusp Alfa
  • Houston, Texas
    M D Anderson Cancer Center
Oct 13, 2021